Recalls / Class II
Class IID-0523-2022
Product
3-Component Cold Tabs (Acetaminophen 325 mg, Guaifenesin 200 mg, Phenylephrine HCl 5mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-106-00
- Affected lot / code info
- Product Code C106L; Bulk lots: 18J080, 18L029, 19A103, 19B063, 19D019, 19F065, Product Code C106LA; Bulk lots: 18K045, 18K046, 18L008, 18L105, 19A068, 19A094, 19A106, 19B009, 19C031, 19C032, 19C033, 19G085, 19H070, 19D018, 19H071, 19H082, 19J027
Why it was recalled
CGMP Deviations
Recalling firm
- Firm
- ULTRAtab Laboratories, Inc.
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 50 Toc Dr, N/A, Highland, New York 12528-1506
Distribution
- Quantity
- 33,758,436 tablets
- Distribution pattern
- Bulk product was distributed to 3 distributors who may have distributed finished product.
Timeline
- Recall initiated
- 2022-01-26
- FDA classified
- 2022-02-09
- Posted by FDA
- 2022-02-16
- Terminated
- 2025-01-07
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0523-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.